[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100442360":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":24,"responsibleParty":93,"collaborators":10,"id":95,"slug":96,"hasResults":97,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":10,"eligibilityCriteria":101,"healthyVolunteers":97,"sex":102,"minAge":10,"maxAge":10,"enrollmentInfo":103,"targetDuration":10,"studyType":106,"phases":10,"briefSummary":107,"conditions":108,"keywords":111,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":126},{"fullName":5,"class":6},"Alnylam Pharmaceuticals","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patisiran",null,"Pregnant women exposed to commercial patisiran-LNP (ONPATTRO) during the 12 weeks prior to their last menstrual period (LMP) or at any time during pregnancy.",[13],{"name":14,"affiliation":5,"role":15},"Medical Director","STUDY_DIRECTOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Alnylam Clinical Trial Information Line","CONTACT","1-877-ALNYLAM","clinicaltrials@alnylam.com",{"name":18,"role":19,"phone":23,"phoneExt":10,"email":21},"1-877-256-9526",[25,39,48,57,66,75,84],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":10},"Clinical Trial Site","RECRUITING","Iowa City","Iowa","52242","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-91.53017,41.66113,{"lat":37,"lon":36},{"facility":26,"status":27,"city":40,"state":10,"zip":10,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":47,"contacts":10},"Nantes","France","FR",{"type":34,"coordinates":44},[45,46],-1.55336,47.21725,{"lat":46,"lon":45},{"facility":26,"status":27,"city":49,"state":10,"zip":10,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":56,"contacts":10},"Münster","Germany","DE",{"type":34,"coordinates":53},[54,55],7.62571,51.96236,{"lat":55,"lon":54},{"facility":26,"status":27,"city":58,"state":10,"zip":10,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":65,"contacts":10},"Pavia","Italy","IT",{"type":34,"coordinates":62},[63,64],9.15917,45.19205,{"lat":64,"lon":63},{"facility":26,"status":27,"city":67,"state":10,"zip":10,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":74,"contacts":10},"Groningen","Netherlands","NL",{"type":34,"coordinates":71},[72,73],6.56667,53.21917,{"lat":73,"lon":72},{"facility":26,"status":27,"city":76,"state":10,"zip":10,"country":77,"countryCode":78,"cosmosGeoPoint":79,"geoPoint":83,"contacts":10},"Lisbon","Portugal","PT",{"type":34,"coordinates":80},[81,82],-9.1498,38.72509,{"lat":82,"lon":81},{"facility":26,"status":27,"city":85,"state":10,"zip":10,"country":86,"countryCode":87,"cosmosGeoPoint":88,"geoPoint":92,"contacts":10},"Madrid","Spain","ES",{"type":34,"coordinates":89},[90,91],-3.70256,40.4165,{"lat":91,"lon":90},{"type":94,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100442360","patisiran-lipid-nanoparticle-lnp-pregnancy-surveillance-program-100442360",false,"NCT05040373","Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program","Patisiran-LNP Pregnancy Surveillance Program","Inclusion Criteria:\n\n* Documentation that the patient was exposed to patisiran-LNP at any point starting from 12 weeks before LMP or at any point during pregnancy\n\nExclusion Criteria:\n\n* There are no exclusion criteria for participation in this program.","FEMALE",{"count":104,"type":105},10,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal\u002Fneonatal\u002Finfant outcomes in women exposed to patisiran-LNP.",[109,110],"Hereditary Transthyretin-mediated (hATTR) Amyloidosis","Polyneuropathy",[112,113,114,115,116],"Hereditary neuropathic amyloidosis","Familial amyloidosis","Amyloidosis","Amyloidosis senile","Cardiac amyloidosis","2026-05-28",{"date":119,"type":120},"2026-06-01","ACTUAL",{"date":122,"type":120},"2020-08-01",{"date":124,"type":105},"2030-10-12",{"name":5,"class":6},7]